Drug intelligence / Profile preview

Shugan Jianwei Pills

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Shugan Jianwei Pills (also known as Shugan Jianwei Wan) are a traditional Chinese medicine (TCM) herbal formulation widely used in China to treat gastrointestinal and digestive disorders. The formulation is composed of a complex mixture of fifteen herbal ingredients, including *Magnolia officinalis* (ginger-prepared), *Cyperus rotundus* (vinegar-prepared), *Paeonia lactiflora* (white peony root), *Bupleurum chinense*, *Citrus reticulata* (tangerine peel and green peel), and *Corydalis yanhusuo*, among others. It is primarily indicated for the treatment of liver-stomach disharmony, which manifests as epigastric distension and pain, chest and hypochondriac fullness, vomiting, acid regurgitation, abdominal distension, and constipation. Shugan Jianwei Pills function by soothing the liver, regulating qi, strengthening the spleen, and harmonizing the stomach. The product is manufactured by several pharmaceutical companies in China, including Shanxi Huakang Pharmaceutical and Beijing Tongrentang, and is available as oral water pills.

Brand names
HexiLixiaoMulinWanglong
Other names
Shugan Jianwei Wan舒肝健胃丸

Beyond the preview

Go deeper on Shugan Jianwei Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shugan Jianwei Pills.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call